FDA advisors back Lilly’s Alzheimer’s drug, setting stage for approval after delay

An FDA advisory committee gave its strong backing to Eli Lilly’s Alzheimer’s drug donanemab, giving further support for the agency’s expected approval after a surprise …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Canadian Cannabis Sales Pick Up Slightly in May

Statistics Canada released May retail sales for the country, with cannabis sales rising from the April levels, up 1.2% to C$415.6 million. April was revised slightly lower

July 21, 2023

GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

May 26, 2024

AEVIS VICTORIA SA – Fabrice Zumbrunnen to become CEO of AEVIS VICTORIA SA as of May 1, 2024 – Biotech Investments

AEVIS VICTORIA SA / Key word(s): Personnel/Personnel 12-March-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

March 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.